CareDx (CDNA) Misses Q2 EPS by 9c, Maintains FY Rev. Guidance

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.27), $0.09 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $7.13 million versus the consensus estimate of $7.28 million.

CareDx sees FY2015 revenue of $28-30 million, versus the consensus of $29.60 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• RH (RH) Tops Q2 EPS by $2.31
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says